Related references
Note: Only part of the references are listed.Valproic acid promotes a decrease in mycobacterial survival by enhancing nitric oxide production in macrophages stimulated with IFN-γ
Erik Nieto-Patlan et al.
TUBERCULOSIS (2019)
An Integrated View of Immunometabolism
Yun Sok Lee et al.
CELL (2018)
Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis
Martin Rao et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Epigenetics and Trained Immunity
Charlotte D. C. C. van der Heijden et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Sodium valproate modulates immune response by alternative activation of monocyte-derived macrophages in systemic lupus erythematosus
Saeed Mohammadi et al.
CLINICAL RHEUMATOLOGY (2018)
Valproic Acid and Lithium Meditate Anti-Inflammatory Effects by Differentially Modulating Dendritic Cell Differentiation and Function
Sy-Jye Leu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Histone deacetylase inhibitor SAHA mediates mast cell death and epigenetic silencing of constitutively active D816V KIT in systemic mastocytosis
Katarina Lyberg et al.
ONCOTARGET (2017)
Regulation of Nitrogen Mustard-Induced Lung Macrophage Activation by Valproic Acid, a Histone Deacetylase Inhibitor
Alessandro Venosa et al.
TOXICOLOGICAL SCIENCES (2017)
DNA Methylation Changes in Valproic Acid-Treated HeLa Cells as Assessed by Image Analysis, Immunofluorescence and Vibrational Microspectroscopy
Giovana M. B. Veronezi et al.
PLOS ONE (2017)
The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3
Lulu Ni et al.
SCIENTIFIC REPORTS (2017)
Butyrate enhances antibacterial effects while suppressing other features of alternative activation in IL-4-induced macrophages
Maria R. Fernando et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Loperamide Restricts Intracellular Growth of Mycobacterium tuberculosis in Lung Macrophages
Esmeralda Juarez et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Incidence of Neutropenia With Valproate and Quetiapine Combination Treatment in Subjects With Acquired Brain Injuries
Hee Jung Park et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2016)
Role of TET enzymes in DNA methylation, development, and cancer
Kasper Dindler Rasmussen et al.
GENES & DEVELOPMENT (2016)
Trained immunity: A program of innate immune memory in health and disease
Mihai G. Netea et al.
SCIENCE (2016)
Immunometabolic circuits in trained immunity
Rob J. W. Arts et al.
SEMINARS IN IMMUNOLOGY (2016)
Modulation of Donor-Specific Antibody Production After Organ Transplantation by Valproic Acid: A Histone Deacetylase Inhibitor
Junsheng Ye et al.
TRANSPLANTATION (2016)
Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance
Haibin Jin et al.
VIROLOGY JOURNAL (2016)
Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma/delta T-cells
Jaydeep Bhat et al.
ONCOTARGET (2016)
Non-catalytic roles for TET1 protein negatively regulating neuronal differentiation through srGAP3 in neuroblastoma cells
Jie Gao et al.
PROTEIN & CELL (2016)
Sodium Valproate Exacerbating an Underlying Disorder of Fatty Acid Metabolism
Jamie Bellinge et al.
CASE REPORTS IN NEUROLOGY (2016)
A guide to immunometabolism for immunologists
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat
Sabbir Khan et al.
BIOCHIMIE (2015)
Modulation of human gamma/delta T-cell activation and phenotype by histone deacetylase inhibitors
Jaydeep Bhat et al.
CELLULAR IMMUNOLOGY (2015)
Valproate modulates glucose metabolism in patients with epilepsy after first exposure
Aleksei Rakitin et al.
EPILEPSIA (2015)
Valproic Acid Ameliorates Graft-versus-Host Disease by Downregulating Th1 and Th17 Cells
Jun Long et al.
JOURNAL OF IMMUNOLOGY (2015)
Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid
Elisabeth Ersvaer et al.
BMC PHARMACOLOGY & TOXICOLOGY (2015)
Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response
Hong Zan et al.
FRONTIERS IN IMMUNOLOGY (2015)
Genome-Wide Analysis Reveals Selective Modulation of microRNAs and mRNAs by Histone Deacetylase Inhibitor in B Cells Induced to Undergo Class-Switch DNA Recombination and Plasma Cell Differentiation
Tian Shen et al.
FRONTIERS IN IMMUNOLOGY (2015)
Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion
Mark Schiebler et al.
EMBO MOLECULAR MEDICINE (2015)
Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway
Pengfei Shi et al.
BMC CANCER (2014)
Dendritic cell development requires histone deacetylase activity
Heike Chauvistre et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Modulation of Treg function improves adenovirus vector-mediated gene expression in the airway
Y. Nagai et al.
GENE THERAPY (2014)
Histone deacetylase inhibitor valproic acid affects plasmacytoid dendritic cells phenotype and function
Jessy Arbez et al.
IMMUNOBIOLOGY (2014)
A novel mechanism for inhibition of lipopolysaccharide-induced proinflammatory cytokine production by valproic acid
Ulziisaikhan Jambalganiin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
The Response of Secondary Genes to Lipopolysaccharides in Macrophages Depends on Histone Deacetylase and Phosphorylation of C/EBPβ
Neus Serrat et al.
JOURNAL OF IMMUNOLOGY (2014)
Histone Deacetylase Inhibitors Upregulate B Cell microRNAs That Silence AID and Blimp-1 Expression for Epigenetic Modulation of Antibody and Autoantibody Responses
Clayton A. White et al.
JOURNAL OF IMMUNOLOGY (2014)
Valproic Acid Prevents Penile Fibrosis and Erectile Dysfunction in Cavernous Nerve-Injured Rats
Johanna L. Hannan et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Glutamine Oxidation Maintains the TCA Cycle and Cell Survival during Impaired Mitochondrial Pyruvate Transport
Chendong Yang et al.
MOLECULAR CELL (2014)
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors
T. Montero-Melendez et al.
CELL DEATH AND DIFFERENTIATION (2013)
Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation
Bilegtsaikhan Tsolmongyn et al.
CELLULAR IMMUNOLOGY (2013)
DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells
Alba Fernandez-Sanchez et al.
EPIGENETICS (2013)
Histone deacetylase inhibition by Japanese encephalitis virus in monocyte/macrophages: A novel viral immune evasion strategy
Dwaipayan Adhya et al.
IMMUNOBIOLOGY (2013)
Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid
Anne-Kathrin Kienzler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
HDAC Inhibition Suppresses Cardiac Hypertrophy and Fibrosis in DOCA-Salt Hypertensive Rats via Regulation of HDAC6/HDAC8 Enzyme Activity
Hae Jin Kee et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2013)
Valproic acid pathway: pharmacokinetics and pharmacodynamics
Yogita Ghodke-Puranik et al.
PHARMACOGENETICS AND GENOMICS (2013)
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
E. L. Pearce et al.
SCIENCE (2013)
Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes
Gang Li et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2013)
Influence of histone deacetylase inhibitors and DNA-methyltransferase inhibitors on the NK cell-mediated lysis of pediatric B-lineage leukemia
Matthias Manuel Pfeiffer et al.
FRONTIERS IN ONCOLOGY (2013)
Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma
Song Gu et al.
ANTI-CANCER DRUGS (2012)
Histone Deacetylase Inhibition by Sodium Valproate Regulates Polarization of Macrophage Subsets
Chenming Wu et al.
DNA AND CELL BIOLOGY (2012)
Impact of HDAC inhibitors on dendritic cell functions
Jihane Frikeche et al.
EXPERIMENTAL HEMATOLOGY (2012)
Valproic acid inhibits proliferation of EB virus-infected natural killer cells
Kazuyasu Fujii et al.
HEMATOLOGY (2012)
Impact of valproic acid on dendritic cells function
Jihane Frikeche et al.
IMMUNOBIOLOGY (2012)
HDACi: molecular mechanisms and therapeutic implications in the innate immune system
Bandar Ali Suliman et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
Omar Khan et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Loss of Transcription Factor Nuclear Factor-Erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Leads to Dysregulation of Immune Functions, Redox Homeostasis, and Intracellular Signaling in Dendritic Cells
Han Xian Aw Yeang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Antiepileptic Drug Valproic Acid Restores T Cell Homeostasis and Ameliorates Pathogenesis of Experimental Autoimmune Encephalomyelitis
Jie Lv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Valproic Acid Treatment Is Associated With Altered Leukocyte Subset Development
Marije Bartels et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression
Lucas E. Rossi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury
Jee Y. Lee et al.
JOURNAL OF NEUROCHEMISTRY (2012)
The Histone Deacetylase Inhibitor Valproic Acid Lessens NK Cell Action against Oncolytic Virus-Infected Glioblastoma Cells by Inhibition of STAT5/T-BET Signaling and Generation of Gamma Interferon
Christopher A. Alvarez-Breckenridge et al.
JOURNAL OF VIROLOGY (2012)
Valproic Acid-Induced Eosinophilic Pleural Effusion A Case Report and Review of the Literature
Zvi Kamenetsky et al.
NEUROLOGIST (2012)
VALPROIC ACID AMELIORATES INFLAMMATION IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS RATS
Z. Zhang et al.
NEUROSCIENCE (2012)
Effect of valproic acid on acute lung injury in a rodent model of intestinal ischemia reperfusion
Kyuseok Kim et al.
RESUSCITATION (2012)
Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway
Sebastien Chateauvieux et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection
Thierry Roger et al.
BLOOD (2011)
Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSPT lymphocytes
Gildas Belrose et al.
BLOOD (2011)
Secretion of MIP-1 beta and MIP-1 alpha by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage
Kevin O. Saunders et al.
CELLULAR IMMUNOLOGY (2011)
Protective effects of valproic acid against airway hyperresponsiveness and airway remodeling in a mouse model of allergic airways disease
Simon G. Royce et al.
EPIGENETICS (2011)
Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate
A. Chavez-Blanco et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Histone Deacetylase Inhibitors Impair Antibacterial Defenses of Macrophages
Matteo Mombelli et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Valproic Acid Attenuates Proteinuria and Kidney Injury
Katrien Van Beneden et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Eosinophilic pleural effusion related to taking valproic acid
C. Bally et al.
REVUE DE PNEUMOLOGIE CLINIQUE (2011)
VALPROIC ACID INCREASES SUSCEPTIBILITY TO ENDOTOXIN SHOCK THROUGH ENHANCED RELEASE OF HIGH-MOBILITY GROUP BOX 1
Shinsuke Sugiura et al.
SHOCK (2011)
Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+Tregs
Tatiana Akimova et al.
CLINICAL IMMUNOLOGY (2010)
Bryostatin-1 Synergizes with Histone Deacetylase Inhibitors to Reactivate HIV-1 from Latency
Moises Perez et al.
CURRENT HIV RESEARCH (2010)
Valproate induces DNA demethylation in nuclear extracts from adult mouse brain
Erbo Dong et al.
EPIGENETICS (2010)
Chronic Administration of Valproic Acid Inhibits Activation of Mouse Hepatic Stellate Cells In Vitro and In Vivo
Inge Mannaerts et al.
HEPATOLOGY (2010)
The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro
Shay Matalon et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Valproate Treatment of Human Cord Blood CD4-positive Effector T Cells Confers on Them the Molecular Profile (MicroRNA Signature and FOXP3 Expression) of Natural Regulatory CD4-positive Cells through Inhibition of Histone Deacetylase
Hussein Fayyad-Kazan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Molecular and Therapeutic Potential and Toxicity of Valproic Acid
Sebastien Chateauvieux et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Valproate Increases Glutaminase and Decreases Glutamine Synthetase Activities in Primary Cultures of Rat Brain Astrocytes
Roger M. Collins et al.
JOURNAL OF NEUROCHEMISTRY (2010)
How GABA generates depolarization
Nicholas C. Spitzer
JOURNAL OF PHYSIOLOGY-LONDON (2010)
Is There a Future for Histone Deacetylase Inhibitors in the Pharmacotherapy of Psychiatric Disorders?
Dennis R. Grayson et al.
MOLECULAR PHARMACOLOGY (2010)
Neutrophilic differentiation modulates the apoptotic response of HL-60 cells to sodium butyrate and sodium valproate
J. Vrba et al.
NEOPLASMA (2010)
Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+Cell Infection
Nancie M. Archin et al.
PLOS ONE (2010)
Epigenetic regulation of CD8+T-lymphocyte mediated suppression of HIV-1 replication
Kevin O. Saunders et al.
VIROLOGY (2010)
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Julia M. Wagner et al.
Clinical Epigenetics (2010)
Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection
Barbara Monti et al.
Current Molecular Pharmacology (2010)
Divalproex Sodium-Induced Eosinophilic Pleural Effusion
Prachi Joshi et al.
AMERICAN JOURNAL OF THERAPEUTICS (2009)
Clinical and Biological Effects of Valproic Acid as a Histone Deacetylase Inhibitor on Tumor and Surrogate Tissues: Phase I/II Trial of Valproic acid and Epirubicin/FEC
Pamela Munster et al.
CLINICAL CANCER RESEARCH (2009)
Effect of Aging on Glucuronidation of Valproic Acid in Human Liver Microsomes and the Role of UDP-Glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10
Upendra A. Argikar et al.
DRUG METABOLISM AND DISPOSITION (2009)
Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis
Sandra J. Saouaf et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas-deficient MRL/lpr-/- murine model of autoimmune lymphoproliferative syndrome (ALPS)
Kennichi C. Dowdell et al.
EXPERIMENTAL HEMATOLOGY (2009)
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
Nancy M. Archin et al.
AIDS (2008)
Delayed-onset neutropenia with divalproex sodium
Steven C. Stoner et al.
ANNALS OF PHARMACOTHERAPY (2008)
Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors
Alfonso Duenas-Gonzalez et al.
CANCER TREATMENT REVIEWS (2008)
Valproic acid attenuates inflammation in experimental autoimmune neuritis
Z. Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review
M. F. B. Silva et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Deacetylase inhibition promotes the generation and function of regulatory T cells
Ran Tao et al.
NATURE MEDICINE (2007)
Stat1 acetylation inhibits inducible nitric oxide synthase expression in interferon-γ-treated RAW264.7 murine macrophages
Lucie Guo et al.
SURGERY (2007)
Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity
Alessio Nencioni et al.
CLINICAL CANCER RESEARCH (2007)
Valproic acid-induced eosinophilic pleural effusion: A case report and review of the literature
Wendy Bullington et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2007)
Histone deacetylase inhibitors suppress natural killer cell cytolytic activity
Henry Ogbomo et al.
FEBS LETTERS (2007)
Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes
Snezana Milutinovic et al.
CARCINOGENESIS (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection
Angelina Jane Mosley et al.
BLOOD (2006)
Histone hyperacetylation is associated with amelioration of experimental colitis in mice
Rainer Glauben et al.
JOURNAL OF IMMUNOLOGY (2006)
Valproic acid induces caspase 3-mediated apoptosis in microglial cells
M. Dragunow et al.
NEUROSCIENCE (2006)
The histone code at DNA breaks: A guide to repair?
H van Attikum et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment
MD Stewart et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Valproate-induced eosinophilia in children with epilepsy: Role of interleukin-5
AC Makis et al.
JOURNAL OF CHILD NEUROLOGY (2005)
Histone deacetylase is a target of valproic acid-mediated cellular differentiation
N Gurvich et al.
CANCER RESEARCH (2004)
Valproic acid-induced eosinophilic pleural effusion
JD Kravetz et al.
SOUTHERN MEDICAL JOURNAL (2003)
Valproic acid-induced neutropenia
KS Vesta et al.
ANNALS OF PHARMACOTHERAPY (2003)
Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells
N Koyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Sodium valproate inhibits production of TNF-α and IL-6 and activation of NF-κB
T Ichiyama et al.
BRAIN RESEARCH (2000)
The language of covalent histone modifications
BD Strahl et al.
NATURE (2000)
Share Paper
